Following the exercise bout at 50 percent of maximal, the carnitine group used 55 percent less muscle glycogen than the control group indicating that they burned more fat for fuel and had improved energy production
The study showed a 13% reduction in major adverse cardiovascular events (MACE), a composite endpoint for cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke, in patients treated with liraglutide compared with placebo at a mean follow-up of 3.8 years (hazard ratio [HR] 0.87, 95% confidence interval [CI] 0.780.97) and a significant reduction in cardiovascular death (HR 0.78, 95% CI 0.660.93)
Stay hydrated to support overall skin health
13% decrease in subcutaneous fat mass 30% reduction of intra-abdominal fat mass 3-11% lean body mass increase 11-19% improvement in aerobic function Muscle strength increases between 7-19% After one year, participants saw overall body fat reduction, with the most significant results in the abdomen, with belly fat reduction at a notable 61%
When should I take L-Carnitine for best results
Gut (2020) 69(8):142331